D-0453-2026 Class II Ongoing

Recalled by Owen Biosciences Inc. — Baton Rouge, LA

FDA drug recall D-0453-2026 was initiated by Owen Biosciences Inc. on Mar 3, 2026 and is designated Class II. Reason for recall: Chemical contamination: Presence of benzene The recall status is ongoing. Affected quantity: 9,850 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 22, 2026
Initiation Date
Mar 3, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,850 bottles

Product description

HydroPeptide CLEAR ALLIANCE SERUM, 2.5% BENZOYL PEROXIDE, a)1 FL OZ/30ml; b) 2 FL OZ/60ml spray bottle; DIST BY HYDROPEPTIDE LLC, ISSAQUAH, WA 98027

Reason for recall

Chemical contamination: Presence of benzene

Distribution pattern

U.S. Nationwide

Code information

Lot# 2518800, Exp.: 4/30/2027 Lot# 2518900, Exp.: 4/1/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0453-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0453-2026. Report a data issue: hello@regdatalab.com.